Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Aradigm
Biotech
Grifols buys antibiotic assets from bankrupt partner Aradigm
The agreement sees Grifols waive a $32 million debt and pay $3 million in cash to take full ownership of three assets.
Nick Paul Taylor
Feb 24, 2020 8:57am
End of the line looms for Aradigm as it files for bankruptcy
Feb 19, 2019 10:46am
Aradigm executives jump ship after FDA snub
Feb 14, 2018 11:15am
FDA demands 2-year phase 3 from Aradigm
Jan 29, 2018 10:47am
Aradigm crashes after FDA panel votes down antibiotic
Jan 12, 2018 6:29am
